Earnings From Small Cap Stocks (HDSN, IMMU, ZIOP)

Hudson Technologies, Inc. (NASDAQ:HDSN) plunged 6.21% to $1.66. The company announced results for the third quarter and nine months ended September 30, 2010. Revenues for the three months ended September 30, 2010 increased 23% to $7,996,000 from $6,499,000 in the comparable 2009 period. Gross profit margins improved to 23% of sales for the third quarter compared to 10% of sales in the third quarter last year. The company reported net income of $200,000, or $0.01 per basic and diluted share, for the third quarter of 2010, compared to a net loss of $658,000, or a loss of $0.03 per basic and diluted share, for the third quarter of 2009. The stock opened at $1.72 and is trading within the range of $1.66-$1.72. The stock went up more than 16% year-to-date. Immunomedics, Inc. (NASDAQ:IMMU) added 0.26% to $3.89. The company reported financial results for the first quarter ended September 30, 2010. The Company reported total revenues of $1.5 million and a net loss of $6.5 million, or $0.09 per share, for the first quarter of fiscal year 2011, which ended September 30, 2010. This compares to total revenues of $39.0 million and net income of $32.0 million, or $0.42 per share, for the same period last year. At current market price, the market capitalization of the company stands at $292.96 million. ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) soared 7.46% to $4.61. The company reported its financial results for the three months ended September 30, 2010. For the third quarter of 2010, the Company’s cash used in operations was $5.8 million, an increase of $3.7 million from $2.1 million for the same period for 2009. The Company reported net loss from operations for the third quarter of 2010 of $8.5 million, or $(0.18) per basic share, compared to a net loss from operations of $2.6 million, or $(0.12) per share in the third quarter of 2009.
tdp2664
Newsworthy Stocks